BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24881860)

  • 1. Epidermal growth factor receptor is a prognosis predictor in patients with esophageal squamous cell carcinoma.
    Zhang W; Zhu H; Liu X; Wang Q; Zhang X; He J; Sun K; Liu X; Zhou Z; Xu N; Xiao Z
    Ann Thorac Surg; 2014 Aug; 98(2):513-9. PubMed ID: 24881860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
    Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
    Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma.
    Jia J; Cui Y; Lu M; Wang X; Li J; Li J; Li Y; Zhang X; Gao J; Zhou J; Lu Z; Gong J; Yu J; Sun Z; Liu C; Shen L; Zhang X
    Clin Transl Oncol; 2016 Jun; 18(6):592-8. PubMed ID: 26459251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of epidermal growth factor receptor is an independent prognostic factor for esophageal squamous cell carcinoma.
    Wang Q; Zhu H; Xiao Z; Zhang W; Liu X; Zhang X; He J; Sun K; Wang L; Xu N
    World J Surg Oncol; 2013 Oct; 11():278. PubMed ID: 24131756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
    Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
    Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy.
    Hickey K; Grehan D; Reid IM; O'Briain S; Walsh TN; Hennessy TP
    Cancer; 1994 Sep; 74(6):1693-8. PubMed ID: 7915963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma.
    Cui Y; Dong C; Wu BQ; Duan XC; Shi G; Gong M; Wang TY
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C44-8. PubMed ID: 26323923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification.
    Itakura Y; Sasano H; Shiga C; Furukawa Y; Shiga K; Mori S; Nagura H
    Cancer; 1994 Aug; 74(3):795-804. PubMed ID: 8039107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of CD133 expression in esophageal squamous cell carcinoma.
    Okamoto H; Fujishima F; Nakamura Y; Zuguchi M; Ozawa Y; Takahashi Y; Miyata G; Kamei T; Nakano T; Taniyama Y; Teshima J; Watanabe M; Sato A; Ohuchi N; Sasano H
    World J Surg Oncol; 2013 Mar; 11():51. PubMed ID: 23448401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin.
    Yamamoto Y; Yamai H; Seike J; Yoshida T; Takechi H; Furukita Y; Kajiura K; Minato T; Bando Y; Tangoku A
    Ann Surg Oncol; 2012 Mar; 19(3):757-65. PubMed ID: 21947696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
    Liu L; Yang Z; Ni W; Xuan Y
    Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A histopathologic and immunohistochemical study of prognostic factors in esophageal squamous cell carcinoma].
    Wang Y; Chen J; Meng L; Liu J; Du D; Zou Y
    Zhonghua Bing Li Xue Za Zhi; 2000 Aug; 29(4):267-71. PubMed ID: 11866922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.
    Yang YL; Xu KL; Zhou Y; Gao X; Chen LR
    Chin Med J (Engl); 2012 Feb; 125(3):450-4. PubMed ID: 22490401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.
    Alterio D; Marvaso G; Maffini F; Gandini S; Chiocca S; Ferrari A; Preda L; Rocca MC; Lepanto D; Fodor C; Volpe S; Dicuonzo S; Laudati A; Giugliano G; Ansarin M; Jereczek-Fossa BA
    Med Oncol; 2017 Jun; 34(6):107. PubMed ID: 28452036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor).
    Inada S; Koto T; Futami K; Arima S; Iwashita A
    Surg Today; 1999; 29(6):493-503. PubMed ID: 10385363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of elevated ERK expression and its positive correlation with EGFR in Kazakh patients with esophageal squamous cell carcinoma.
    Cui X; Li S; Li T; Pang X; Zhang S; Jin J; Hu J; Liu C; Yang L; Peng H; Jiang J; Liang W; Suo J; Li F; Chen Y
    Int J Clin Exp Pathol; 2014; 7(5):2382-91. PubMed ID: 24966948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
    Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIF-2C expression is correlated with poor prognosis of operable esophageal squamous cell carcinoma male patients.
    Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Fu XY; Ma QL; Wang XY; Lin P
    Oncotarget; 2016 Dec; 7(49):80493-80507. PubMed ID: 27563815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.